ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+15.27%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$403M
AUM Growth
+$403M
(+8.7%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
3.68%
Top 10 Holdings %
Top 10 Hldgs %
78.78%
Holding
83
New
7
Increased
10
Reduced
7
Closed
11
Top Buys
| 1 |
argenx
ARGX
|
$6.74M |
| 2 |
Gyre Therapeutics
GYRE
|
$6.14M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$5.85M |
| 4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$5.73M |
| 5 |
VRAY
ViewRay, Inc.
VRAY
|
$5.4M |
Top Sells
| 1 |
DBVT
DBV Technologies
DBVT
|
$8.15M |
| 2 |
Amicus Therapeutics
FOLD
|
$3.69M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$3.41M |
| 4 |
Forte Biosciences
FBRX
|
$3.13M |
| 5 |
PDS Biotechnology
PDSB
|
$2.9M |
Sector Composition
| 1 | Healthcare | 67.92% |
| 2 | Communication Services | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $109M | 20.59% | 6,750,000 +12,294 | +0.2% | +$199K |
|
2
Assembly Biosciences
ASMB
$190M
| $49.2M | 9.29% | 1,087,104 +87,104 | +9% | +$3.94M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $31.1M | 5.88% | 3,892,000 +460,191 | +13% | +$3.68M |
|
4
Veracyte
VCYT
$2.39B
| $21.5M | 4.06% | 3,295,111 | – | – |
|
5
Ascendis Pharma
ASND
$11.8B
| $21.3M | 4.02% | 531,000 +31,000 | +6% | +$1.24M |
|
|
6
argenx
ARGX
$43.6B
| $20.4M | 3.85% | 323,000 +106,745 | +49% | +$6.74M |
|
|
KDMN
7
DELISTED
Kadmon Holdings, Inc.
KDMN
| $17.8M | 3.36% | 4,915,000 +1,581,667 | +47% | +$5.73M |
|
|
VRAY
8
DELISTED
ViewRay, Inc.
VRAY
| $17.7M | 3.35% | 1,915,654 +583,671 | +44% | +$5.4M |
|
9
IRIDEX
IRIX
$22.8M
| $15.2M | 2.88% | 2,000,000 | – | – |
|
|
CEMI
10
DELISTED
Chembio diagnostics, Inc.
CEMI
| $14.1M | 2.66% | 1,721,299 | – | – |
|
11
Indaptus Therapeutics
INDP
$7.19M
| $14M | 2.65% | 2,724,283 | – | – |
|
|
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
| $12M | 2.27% | 300,000 +50,000 | +20% | +$2M |
|
|
13
PDS Biotechnology
PDSB
$57.8M
| $8.84M | 1.67% | 943,906 -309,488 | -25% | -$2.9M |
|
|
14
Gyre Therapeutics
GYRE
$703M
| $6.14M | 1.16% | +450,000 | New | +$6.14M |
|
|
AVXS
15
DELISTED
AveXis, Inc. Common Stock
AVXS
| $5.85M | 1.11% | +52,900 | New | +$5.85M |
|
16
Evolent Health
EVH
$1.12B
| $5.17M | 0.98% | 420,000 -30,000 | -7% | -$369K |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.42M | 0.83% | 900,000 -96,300 | -10% | -$473K |
|
|
MNTA
18
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.34M | 0.82% | +311,169 | New | +$4.34M |
|
|
CASM
19
DELISTED
CAS Medical Systems, Inc.
CASM
| $3.97M | 0.75% | 5,160,000 +66,724 | +1% | +$51.4K |
|
|
NBRV
20
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $3.47M | 0.65% | 580,000 +180,000 | +45% | +$1.08M |
|
|
MRTX
21
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.83M | 0.53% | +155,000 | New | +$2.83M |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.71M | 0.51% | 90,000 -80,000 | -47% | -$2.41M |
|
23
Fennec Pharmaceuticals
FENC
$247M
| $2.51M | 0.47% | 250,000 | – | – |
|
24
Aclaris Therapeutics
ACRS
$209M
| $2.28M | 0.43% | +92,500 | New | +$2.28M |
|
|
VIVE
25
DELISTED
VIVEVE MED INC
VIVE
| $2.15M | 0.41% | 433,419 -393,921 | -48% | -$1.96M |
|